NCT02436226View on ClinicalTrials.gov

Use of Low Dose of HCG During Ovulation Induction With CC in Women With CC Resistant PCOS

PHASE4CompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

January 31, 2023

Study Completion Date

January 31, 2023

Conditions
InfertilityPolycystic Ovarian Syndrome
Interventions
DRUG

Clomiphene citrate and Human chorionic gonadotropin (HCG)

Women will receive clomiphene citrate (150 mg/day for 5 consecutive days from day 2 of cycle) and HCG (200 IU/day SC from day 7 of cycle)

DRUG

Clomiphene citrate

Women will receive clomiphene citrate (150 mg/day for 5 consecutive days from day 2 of cycle)

Trial Locations (1)

35111

Obstetrics and Gynecology Department in Mansoura University Hospital, Al Mansurah

All Listed Sponsors
lead

Mohamed Sayed Abdelhafez

OTHER

NCT02436226 - Use of Low Dose of HCG During Ovulation Induction With CC in Women With CC Resistant PCOS | Biotech Hunter | Biotech Hunter